NCT03881423 is a Phase 4 clinical trial of Rocuronium Bromide in Muscle Relaxation, sponsored by Wahba bakhet.

Who is sponsoring NCT03881423?

NCT03881423 is sponsored by Wahba bakhet.

What drugs are being tested in NCT03881423?

Interventions in NCT03881423: Rocuronium Bromide.

What condition does NCT03881423 study?

NCT03881423 studies Muscle Relaxation.

Is NCT03881423 still recruiting?

NCT03881423 is currently completed. Last updated 29 October 2019.

Last reviewed 2019-10-29 · How we verify

NCT03881423

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Deep vs Moderate Neuromuscular Blockade in Day Case Laparoscopic Cholecystectomy.

Completed Phase 4 Last updated 29 October 2019

What this trial tests

Phase 4 trial testing Rocuronium Bromide in Muscle Relaxation in 80 participants. Completed in 1 July 2019.

Timeline

1 April 2017

Primary endpoint
1 April 2019

1 July 2019

Quick facts

Lead sponsor	Wahba bakhet
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	supportive care
Enrollment	80
Start date	1 April 2017
Primary completion	1 April 2019
Estimated completion	1 July 2019
Sites	1 location across Egypt

Drugs / interventions tested

Rocuronium Bromide (Rocuronium Bromide) — full drug profile →

Conditions studied

Muscle Relaxation — all drugs for Muscle Relaxation →

Sponsor

Wahba bakhet — full company profile →

Who can join

Adults 21 to 60, any sex, with Muscle Relaxation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Laparoscopic cholecystectomy (LC) is commonly performed on ambulatory basis as a result of its ability to improve postoperative quality of recovery (QOR) and significantly reduce hospital stay .

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure.
Bijkerk V, Jacobs LM, Albers KI, Gurusamy KS, et al · · 2024 · cited 2× · PMID 38288876 · DOI 10.1002/14651858.cd013197.pub2

Verify or expand the search:

Other trials of Rocuronium Bromide

Trials testing the same drug.

NCT06399445 — Measurement of Blood Loss in Adenotonsillectomy During General Anesthesia According to the Application of Nondepolarizin · Phase 4 · recruiting
NCT05872451 — Current Intensity for the Obturator Nerve Block · NA · completed
NCT05562999 — Impact of Deep Neuromuscular Blockade During Total Hip Replacement Surgery on Postoperative Recovery and Immune Function · Phase 4 · completed
NCT05687253 — Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing Surgery · Phase 2 · completed
NCT05619848 — Effect of Paravertebral Muscle Fat Infiltration on Rocuronium Use in Lumbar Surgery · EARLY_PHASE1 · completed

Other recruiting trials for Muscle Relaxation

Currently open trials in the same condition.

NCT06707532 — The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA) · NA · recruiting
NCT05736744 — Effect of Magnesium Sulphate Pretreatment in Pediatric Abdominal Surgery · Phase 2, PHASE3 · recruiting

Other Wahba bakhet trials

Trials by the same sponsor.

NCT03980951 — Neuroaxial Labour Analgesia · NA · completed
NCT04105764 — Deep NMB in Ambulatory Gynecological Laparoscopy · Phase 4 · completed
NCT04194294 — Role of LIDOCAINE IN Pediatric Cochlear Implant Surgery · Phase 4 · completed
NCT03721081 — Local Anesthesia for Pediatric Cochlear Implant · Phase 4 · completed
NCT03722940 — Role of Magnesium in Pediatric Cochlear Implant · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03881423 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wahba bakhet
Last refreshed: 29 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03881423.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing